Spots Global Cancer Trial Database for liothyronine
Every month we try and update this database with for liothyronine cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Inducing a Hypothyroxinemic State in Patients With Recurrent Glioblastoma or Gliosarcoma | NCT05017610 | Recurrent Gliob... Recurrent Glios... | Liothyronine Lomustine Methimazole | 18 Years - | Emory University | |
Evaluation Study of L-T3 Utility in the Follow-up of Patients With Thyroid Cancer | NCT00223158 | Thyroid Cancer | Liothyronine | 18 Years - | Université de Sherbrooke | |
Combined Levothyroxine/Liothyronine Supplementation in Hypothyroid Patients With Brain Tumors | NCT00488644 | Hypothyroidism Brain Tumor | Levothyroxine Liothyronine | 18 Years - | M.D. Anderson Cancer Center | |
Energy Metabolism in Thyroidectomized Patients | NCT04782856 | Thyroid Goiter Hypothyroidism Thyroid Cancer | Levothyroxine Liothyronine Placebo | 18 Years - 89 Years | Virginia Commonwealth University | |
131I-Omburtamab, in Recurrent Medulloblastoma and Ependymoma | NCT04743661 | Recurrent Medul... Recurrent Epend... | Irinotecan Temozolomide Bevacizumab Omburtamab I-13... Liothyronine SSKI Dexamethasone Antipyretic Antihistamine anti-emetics | - 21 Years | Pediatric Brain Tumor Consortium | |
Combined Levothyroxine/Liothyronine Supplementation in Hypothyroid Patients With Brain Tumors | NCT00488644 | Hypothyroidism Brain Tumor | Levothyroxine Liothyronine | 18 Years - | M.D. Anderson Cancer Center | |
131I-Omburtamab, in Recurrent Medulloblastoma and Ependymoma | NCT04743661 | Recurrent Medul... Recurrent Epend... | Irinotecan Temozolomide Bevacizumab Omburtamab I-13... Liothyronine SSKI Dexamethasone Antipyretic Antihistamine anti-emetics | - 21 Years | Pediatric Brain Tumor Consortium |